{
    "organizations": [],
    "uuid": "57d477b2f6e0764175bae781b6ca5504458863b2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pledpharma-gets-approval-letter-fr/brief-pledpharma-gets-approval-letter-from-european-patent-office-idUSFWN1RA02Z",
    "ord_in_thread": 0,
    "title": "BRIEF-PledPharma Gets Approval Letter From European Patent Office",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 28 (Reuters) - PLEDPHARMA AB (PUBL):\n* PLEDPHARMA RECEIVES EUROPEAN APPROVAL OF THE COMPOSITION OF MATTER PATENT FOR PLEDOX® AND ALADOTE®\n* ‍EXPIRY DATE FOR PATENT IS DECEMBER, 2032.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-28T14:10:00.000+03:00",
    "crawled": "2018-03-29T15:39:35.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "pledpharma",
        "ab",
        "publ",
        "pledpharma",
        "receives",
        "european",
        "approval",
        "composition",
        "matter",
        "patent",
        "date",
        "patent",
        "december",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}